AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Down 31.1% in January

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 291,500 shares, a decrease of 31.1% from the December 31st total of 423,300 shares. Currently, 7.7% of the shares of the company are sold short. Based on an average daily trading volume, of 465,900 shares, the short-interest ratio is currently 0.6 days.

AquaBounty Technologies Stock Performance

NASDAQ AQB traded up $0.01 during trading hours on Friday, reaching $0.71. The stock had a trading volume of 68,601 shares, compared to its average volume of 306,348. The stock has a fifty day moving average of $0.78 and a 200 day moving average of $1.06. The stock has a market cap of $2.73 million, a P/E ratio of -0.04 and a beta of 1.17. AquaBounty Technologies has a 52-week low of $0.47 and a 52-week high of $2.79. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.98 and a current ratio of 3.02.

AquaBounty Technologies (NASDAQ:AQB) last announced its quarterly earnings results on Tuesday, November 5th. The company reported ($0.88) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.88). AquaBounty Technologies had a negative return on equity of 18.20% and a negative net margin of 5,842.69%. The company had revenue of $0.05 million during the quarter, compared to the consensus estimate of $0.10 million. During the same period in the previous year, the company posted ($1.60) earnings per share.

Institutional Inflows and Outflows

An institutional investor recently raised its position in AquaBounty Technologies stock. Epiq Partners LLC lifted its holdings in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 89,000 shares of the company’s stock after buying an additional 72,000 shares during the quarter. Epiq Partners LLC owned approximately 2.30% of AquaBounty Technologies worth $56,000 as of its most recent SEC filing. Institutional investors own 8.92% of the company’s stock.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.